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Abstract
Lung transplantation has evolved to become an acceptable therapy for individuals with end-stage lung disease. Readmissions rates
after lung transplantation remain high as compared to other medical surgical populations. The purpose of this review is to
synthesize the current body of knowledge about patterns, risk factors, and outcomes of readmissions after lung transplantation.
The literature revealed that the most common admission diagnoses linked to lung transplant readmissions are infections followed
by tachyarrhythmias, airway complications, surgical complications, rejection, thromboembolic events, gastrointestinal complications, and renal dysfunction. Risk factors for these readmissions include male gender, longer intensive care unit stay, reintubation, prolonged chest tube air leak, frailty, and discharge to a long-term care facility. Outcomes of multiple readmissions after
lung transplantation are associated with decreased survival and increased risk of mortality. Further research is needed to better
understand which readmission diagnoses are preventable and whether multidisciplinary interventions can reduce readmission
rates among patients after lung transplantation.
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Clinical Relevancy to Practice
Lung transplantation has evolved to become an approved treatment modality for individuals with end-stage lung disease.
However, current resources attributed to the care of the lung
transplant patient amount to US$236 450 in Medicare costs in
the first posttransplant year alone.1 Complexity of the surgical
procedure and the intricacies of immunosuppression lead to a
number of potential complications resulting in a higher rate of
readmissions after a lung transplant.2,3 Unplanned readmissions not only impact patient’s physical and emotional health
but also increase health care cost.
The purpose of this article was to review the current body of
literature about patterns, risk factors, and outcomes for readmissions after lung transplantation. This information can
inform the design of preventative strategies implemented by
the members of the multidisciplinary team to prevent
unplanned readmissions after lung transplantation.

Practice Issues
Patterns of Readmissions After Lung Transplantation
The literature reviewed confirmed that rehospitalizations were
common after lung transplantation. A few single-institution
retrospective reviews documented a wide range of readmission
rates (30%-92%) at different time trajectories after lung transplant.2-6 For example, the incidence of readmission within 30
days after lung transplant was reported to range between 29.8%
and 45.4%,4-6 which was higher than the documented 19% in

the cardiac surgery literature.7 Although the most common
admission diagnoses in the first month after lung transplant
were infections, respiratory, and pleural space complications
in addition to arrythmias, other causes for subsequent rehospitalizations included surgical complications, allograft rejection,
airway complications, thromboembolic events, gastrointestinal
events, and renal dysfunction (see Table 1).2-6
A retrospective review sought to determine whether there
was an association between transplant center volume (low, less
than 20 patients per year; intermediate, 20-34; or high, 35 or
more) and readmission rate.1 Individuals from a lower volume
transplant hospital had a 14% greater risk for hospital readmission as compared to a high-volume center.1
A study by Courtwright et al8 used a prospective research
methodology to examine incidences, causes, direct cost, and
preventability of readmissions within 30 days after initial discharge after lung transplant surgery for 90 patients. Their readmission rates were reported as 33% lower as compared to
previously documented statistics. Interestingly, 30% of these
readmissions were deemed preventable with (1) improved
communication between inpatient and outpatient providers and
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Table 1. Causes of Readmission Following Lung Transplantation.
Diagnosis
Infection (pneumonia, bronchitis,
aspergillosis, CMV, and other)
Respiratory adverse events (airway
adverse events, respiratory failure,
pulmonary edema)
Pleural space adverse events
Gastrointestinal adverse events
Allograft dysfunction/rejection
Renal dysfunction
Cardiac adverse events
Thromboembolic event

Percent at
30 days

Percent at
1 year

19%-25%2-3,6 22%-36%2-6
34%6

11%-36%2-4,6

20%-26%2,3
6%-14%2,3
3%-15%2,3,6 2%-39%2-4,6
1%-9%3,6
10%-15%3,5,6
3
11%
6%-12%2-4,6
6%-18%2,3,6 2%-24%2-4,6
3%3
1%-4%2-4,6

Abbreviation: CMV, cytomegalovirus.

(2) prescription of an alternative medical regimen at discharge.
Also, unplanned rehospitalizations before 30 days after initial
discharge were found to be more preventable than those that
occurred after 30 days.

Risk Factors for Readmissions After Lung Transplantation
The limited literature in the area of readmissions post-lung
transplantation primarily focused on the nonmodifiable risk
factors such as underlying lung disease, lung allocation score
(LAS), gender, age, length of stay in the intensive care unit, and
complicated hospital course.3-6 It was noted that males, patients
with higher LAS, and those discharged to a long-term care
facility were found to have more readmissions.3 An additional
risk factor for readmissions was a chest tube air leak lasting
more than 5 days after the operation.6 Also, the need for reintubation after initial surgery was associated with unplanned
rehospitalizations. This was not an unexpected finding as reintubation is known to be a prognostic indicator for a reduced
survival after lung transplantation.5 Reintubations are often
linked to allograft dysfunction and are also associated with
other respiratory complications.5
Discharge to a long-term care facility was noted to be a risk
factor for early readmissions.3,5 This is congruent with the
identified risk factor of higher LAS and hence, longer initial
hospitalization for this population of patients as opposed to
those who were discharged home.3 Lung transplant patients
who were discharged to an inpatient rehabilitation facility were
less likely to be readmitted within the first 30 days2 highlighting the importance of the intense physical and pulmonary rehabilitation after transplantation.
Recently, attention has shifted to frailty as a modifiable risk
factor for readmissions after lung transplant.8,9 Courtwright
et al8 demonstrated that frailty was associated with hospital
readmissions up to 3 months following discharge. Frailty, a
concept which emerged from geriatric medicine,10 has been
gaining increased interest in the transplant literature. Its biology is grounded in physiological states associated with aging
such as sarcopenia and diminished activity tolerance resulting

in an increased vulnerability to adverse outcomes and stress
states.9,10 Many screening instruments exist as a measurement
of frailty, but few are validated in the transplant population.
The Short Physical Performance Battery (SPPB) test was chosen as an objective measure of frailty in the Courtwright et al8
study. Patients with lower SPPB scores (indicative of more
frailty) had considerably higher risk of readmission as compared to those with a higher score (indicative of less frailty).
Later, Courtwright et al11 proceeded to investigate changes in
SPPB scores in frail recipients enrolled in an outpatient rehabilitation program with findings that 86% of patients were no
longer frail over a median of 6 weeks.11
Finally, a finding to be highlighted is that patients who
underwent transplant between 2004 and 2010 were at a higher
risk for readmissions than those after 2010,6 which may
account for advances in surgical and immunosuppression techniques of the present decade.

Outcomes of Readmissions After Lung Transplantation
Unplanned rehospitalizations after lung transplantation were
correlated with worse survival even after adjusting for factors
such as sex, age, underlying lung disease, wait time, and length
of stay of the initial hospitalization.3.6 Unplanned readmissions
within the first 60 days,6 3 to 9 months,8 or 38 months6 were all
associated with decreased survival. Individuals who had more
than 2 readmissions during the first year had statistically significant worse 3-year (67% vs 89%) and 5-year (48% vs 80%)
survival rates.2 Patients who were readmitted 4 times in the first
year following transplant, were 4.5 times more likely to die as
compared to those readmitted less or not at all.6 This is of great
significance in the field of lung transplantation, as overall survival is already lower as compared to other solid organs. Any
factors that can be contributing to this decreased survival need
to be investigated and mitigated.
Readmissions after lung transplantation also account for a
substantial price tag with rejection accounting for the highest
cost (median US$10 128) followed by respiratory complications (median US$9381) and thromboembolic events (median
US$8334).6 The median direct hospital cost of a readmission
was estimated to be US$5524.6 In a time where increased
emphasis is placed on decreasing health care costs and improving outcomes within patient populations, it has been recognized
that lung transplantation demands significant resources and
associated expenses.1 Therefore, it is a necessity to reduce cost
without sacrificing outcomes.

Implications for Practice
This literature review suggested that rates of readmission post
lung transplantation were higher as compared to other populations studied in the surgical literature. Although a single readmission was not associated with worse survival, multiple
hospital readmissions were associated with a higher mortality.2
It is unclear from the literature whether deaths were occurring
during these readmissions, or after discharge. One may
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hypothesize that frequent rehospitalizations are indicative of an
increased number of posttransplant complications that ultimately affect posttransplant survival. Mitigating modifiable
risk factors would have a role in decreasing preventable hospital readmissions. For example, objective measures of frailty
pre- and post-lung transplantation can assist health care providers to identify patients at risk for readmissions. Similarly,
timely enrollment in effective rehabilitation programs after
transplantation may have direct effect on the future health care
utilization. This would be congruent with findings that lung
transplant recipients discharged to an inpatient rehabilitation
center experienced fewer readmissions.2
It was noted that discharges from a higher volume transplant
centers correlated with less readmissions as compared to discharges from a lower volume transplant centers.1 It would be
important to identify team practices from these successful institutions and consider including readmissions metrics in the
quality data for each individual center. Further studies of risk
factors as a result from suboptimal patient care can further
improve quality of care and diminish costly strain on the health
care system. Further research should also focus on identifying
social determinants of health linked to the problem of readmissions. These psychosocial contributors may include lack
of caregivers, financial difficulties, poor literacy, problems
with transportation, and so on.
The above data on lung transplant readmissions, all from
single-institution reviews with small sample sizes, may not
fully portray a true burden of readmissions among the lung
transplant patient population. Avoidable or preventable readmissions are poorly defined. Additional research is needed to
understand which admission diagnoses are preventable and
whether interventions studied with other chronic conditions
such as discharge follow-up, improved care coordination
between inpatient and outpatient providers, postdischarge telephonic management, or other interventions can reduce readmission rates among patients after lung transplantation.
Further studies and designs involving multiple transplant centers are needed to evaluate efficacies of the above interventions
with transplant populations and design other creative multidisciplinary approaches to reduce readmissions after lung
transplantation.
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